Results 71 to 80 of about 4,727 (145)
Diagnostic World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) and Diagnostic Group 1' pulmonary veno-occlusive disease (PVOD) and/or pulmonary capillary hemangiomatosis (PCH) are progressive and fatal disorders. Past registries
C. Gregory Elliott +13 more
doaj +1 more source
Heritable pulmonary hypertension: from bench to bedside
Mutations in the BMPR2 gene, and more rarely in ACVRL1, endoglin, caveolin-1, KCNK3 and TBX4 genes predispose to heritable pulmonary arterial hypertension, an autosomal dominant disease with incomplete penetrance. Bi-allelic mutations in the EIF2AK4 gene
Barbara Girerd +3 more
doaj +1 more source
Pulmonary veno‐occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure.
Lavinia Neubert +12 more
doaj +1 more source
Pulmonary veno-occlusive disease [PDF]
C B, Carrington, A A, Liebow
openaire +4 more sources
Pulmonary Veno-Occlusive Disease
Salma Al Kahf +3 more
openaire +1 more source
Pulmonary veno‐occlusive disease (PVOD) is a rare form of pulmonary vascular disease that is difficult to distinguish clinically from pulmonary arterial hypertension (PAH).
Roger Winters +11 more
doaj +1 more source
Acute venodilation properties of low-dose intravenous nitroglycerine in pulmonary veno-occlusive disease: a case report. [PDF]
Maruyama H, Sakai S, Suzuki S.
europepmc +1 more source
A rare compound heterozygous EIF2AK4 mutation in pulmonary veno-occlusive disease. [PDF]
Zhang C, Du Q, Wang S, Zhang R.
europepmc +1 more source
A Challenging Case of Genetically and Histologically Diagnosed Pulmonary Veno-Occlusive Disease with Extracorporeal Life Support and Redo Lung Transplantation. [PDF]
Laimoud M +3 more
europepmc +1 more source

